Literature DB >> 22894991

Robotic assisted reconstruction of the oropharynx.

John R de Almeida1, Eric M Genden.   

Abstract

PURPOSE OF REVIEW: Oropharyngeal reconstruction has undergone significant advances over the last several decades. Transoral robotic surgery (TORS) is a new approach to managing tumors of this location and requires unique reconstructive principles. RECENT
FINDINGS: The advent of TORS has popularized transoral approaches and has presented new challenges related to reconstruction. Although TORS provides a minimally invasive approach to the oropharynx, there is a paucity of data related to reconstruction of extensive defects following TORS. Our institutional practice is to reconstruct defects based on the Classification for Oropharyngeal Robotic Defects (CORD) classification system. The CORD system considers size, location, number of involved oropharyngeal subsites, pharyngocervical communication, and exposure of carotid artery to guide reconstruction. This system uses more advanced reconstructions to manage increasingly complex defects.
SUMMARY: Herein, we present principles of robotic assisted oropharyngeal reconstruction and the method for applying the CORD system.

Entities:  

Mesh:

Year:  2012        PMID: 22894991     DOI: 10.1097/MOO.0b013e328354c24e

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Application of "parachute" technique for free flap reconstruction in advanced tongue cancer after ablation without lip-jaw splitting: A retrospective case study.

Authors:  Chin-Jui Liu; Ku-Hao Fang; Chang-Cheng Chang; Erh-Ti Lin; Geng-He Chang; Jen-Hsiang Shen; Yu-Tsung Chen; Yao-Te Tsai
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

2.  Methodology in Conventional Head and Neck Reconstruction Following Robotic Cancer Surgery: A Bridgehead Robotic Head and Neck Reconstruction.

Authors:  Jongmin Won; Jong Won Hong; Mi Jung Kim; In-Sik Yun; Woo Yeol Baek; Won Jai Lee; Dae Hyun Lew; Yoon Woo Koh; Se-Heon Kim
Journal:  Yonsei Med J       Date:  2022-08       Impact factor: 3.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.